Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Stalmeier, P. F.M.
Right arrow Articles by Van Daal, W. A.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stalmeier, P. F.M.
Right arrow Articles by Van Daal, W. A.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Evaluation of a Shared Decision Making Program for Women Suspected to Have a Genetic Predisposition to Breast Cancer

Preliminary Results

Peep F.M. Stalmeier, PhD

Ivana J. Unic, MD

Lia C.G. Verhoef, MD, PhD

Willem A.J. Van Daal, MD, PhD

Background. Women suspected to have a genetic predisposition to breast cancer face the difficult choice between regular breast cancer screening and prophylactic mastec tomy. The authors developed a shared decision making program (SDMP) to support this decision. Objectives. To evaluate the SDMP in terms of practicality, beneficial effects, and patient satisfaction. Design. A one-group pretest-posttest design was used. Measures. Decision uncertainty, decision burden, subjective knowledge, and risk comprehension were assessed before and after the SDMP. Additional measures were obtained for concepts related to breast cancer concern, desire to participate in the program, satisfaction, program acceptability, and emotional reaction to the program information. Results. Seventy-two women, most of whom were awaiting the genetic test results, participated. Decision uncertainty (effect size d = 0.37) and decision bur den (d= 0.41) were reduced by the SDMP. Subjective knowledge (averaged d= 0.94) and risk comprehension were improved. The women were satisfied with the SDMP and found its rationale acceptable. Women who had strong emotional reactions to the information benefited less from the SDMP, whereas women with strong desires to participate in the decision benefited more. Conclusions. There is a need to give pa tients more information, especially about prophylactic mastectomy and among gene carriers. Beneficial effects were observed irrespective of whether genetic status was known, suggesting that information concerning treatment options should be made available as soon as DNA testing begins. The better psychological outcomes of women with stronger desires to participate may arise because the desire to participate is char acteristic of emotional stability. Key words: shared decision making; breast cancer; genetic predisposition; patient participation; patient satisfaction. (Med Decis Making 1999; 19:230-241)

Medical Decision Making, Vol. 19, No. 3, 230-241 (1999)
DOI: 10.1177/0272989X9901900302


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCOHome page
M.S. van Roosmalen, P.F.M. Stalmeier, L.C.G. Verhoef, J.E.H.M. Hoekstra-Weebers, J.C. Oosterwijk, N. Hoogerbrugge, U. Moog, and W.A.J. van Daal
Randomized Trial of a Shared Decision-Making Intervention Consisting of Trade-Offs and Individualized Treatment Information for BRCA1/2 Mutation Carriers
J. Clin. Oncol., August 15, 2004; 22(16): 3293 - 3301.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
A. S. Elstein, D. G. Fryback, M. C. Weinstein, S. G. Pauker, M. Holmes-Rovner, M. J. Young, M. J. Barry, M. H. Eckman, M. G. M. Hunink, J. Tsevat, et al.
Presidential Reflections on the 25th Anniversary of the Society for Medical Decision Making
Med Decis Making, August 1, 2004; 24(4): 408 - 420.
[PDF]


Home page
Health Educ ResHome page
J. L. Bottorff, C. Richardson, L. G. Balneaves, M. McCullum, J. A. Buxton, P. A. Ratner, and T. Hack
Unraveling women's perceptions of risk for breast cancer
Health Educ. Res., August 1, 2004; 19(4): 469 - 475.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Braithwaite, J. Emery, F. Walter, A. T. Prevost, and S. Sutton
Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-analysis
J Natl Cancer Inst, January 21, 2004; 96(2): 122 - 133.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
L. C. Swartzman, R. A. Harshman, J. Burkell, and M. E. Lundy
What Accounts for the Appeal of Complementary/Alternative Medicine, and What Makes Complementary/Alternative Medicine "Alternative"?
Med Decis Making, October 1, 2002; 22(5): 431 - 450.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
M. H. Eckman
Patient-Centered Decision Making: A View of the Past and a Look toward the Future
Med Decis Making, May 1, 2001; 21(3): 241 - 247.
[PDF]


Home page
Med Decis MakingHome page
S. Molenaar, M. A.G. Sprangers, F. C.E. Postma-Schuit, E. J. Th. Rutgers, J. Noorlander, J. Hendriks, and H. C.J.M. De Haes
Interpretive Review : Feasibility and Effects of Decision Aids
Med Decis Making, January 1, 2000; 20(1): 112 - 127.
[Abstract] [PDF]